Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00308451 · ClinicalTrials.gov registry record · NA
A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM
A NA study, sponsored by Nutrition 21.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT00308451 is a NA study that has completed, run by Nutrition 21. The registered enrollment target is 40 participants.
The verdict
NCT00308451, a NA study, has completed, sponsored by Nutrition 21.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of the proposed work is to assess the effects of a dietary supplement, containing chromium (600 mcg per day) provided by chromium picolinate and biotin (2 mg per day) on glycemic control in type 2 diabetes. Specifically, this study will assess whether use of the supplement will lower the post-prandial rise in blood glucose experienced after ingestion of a 75g carbohydrate load, relative to placebo, in type 2 diabetic patients. The study will also assess the chronic effects of supplementation over a 4-week period (relative to placebo) on fasting plasma levels of glucose, insulin, lipids and lipoproteins.
Interventions
- DRUG Chromium Picolinate (600 mcg Cr+3) + biotin (2 mg)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2003-11 |
| Est. Completion | 2004-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00308451
The ClinicalTrials.gov registry entry for NCT00308451 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nutrition 21, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chromium Picolinate (600 mcg Cr+3) + biotin (2 mg) is the first listed.
NCT00308451 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00308451 about?
NCT00308451 is a clinical study titled "A 30 Day Acute Efficacy and Safety Study of Chromium Picolinate + Biotin on Glycemic Control in Overweight or Obese Subjects With T2DM". The purpose of the proposed work is to assess the effects of a dietary supplement, containing chromium (600 mcg per day) provided by chromium picolinate and biotin (2 mg per day) on glycemic control in type 2 diabetes. Specifically, this study will assess whether use of the supplement will lower the...
What is the current status of trial NCT00308451?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2003-11. Estimated completion is 2004-04.
What interventions are being tested in trial NCT00308451?
The interventions under investigation include: Chromium Picolinate (600 mcg Cr+3) + biotin (2 mg) (DRUG).
Who is sponsoring clinical trial NCT00308451?
This trial is sponsored by Nutrition 21, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.